Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism.

Scientists turned blood cells from autistic and non-autistic siblings into lymphoblastoid cell lines. These are lab-grown cells that keep the donor’s gene activity.

The team checked if the cells gave the same gene-readout twice. They also asked if the readouts could tell the siblings apart.

The cell lines passed the repeat test: same donor, same gene pattern.

Gene profiles from the autistic siblings clustered away from the non-autistic ones. This shows the cells can flag autism-linked genes and pathways.

Vollmer et al. (1996) came first. They drew fresh blood and saw weak immune markers in live autistic kids. Eisenhower et al. (2006) built on that idea but used frozen, renewable cells instead of fresh draws.

Cummings et al. (2024) now steer researchers toward huge, free cohorts like SPARK. Their review folds in the 2006 cell-line trick as a cheap way to mine those samples for gene clues.

Bailey (2008) pushes for more post-mortem brain tissue. Eisenhower et al. (2006) give an easier, living-cell option when brain tissue is scarce.

You may never run a genetics lab, but you do sit in treatment-plan meetings where parents ask about biological tests. This paper gives you a concrete answer: gene-expression snapshots from a simple blood draw can separate autism from typical profiles. As cheaper lab tools spread, you might soon pair behavioral data with a child’s gene readout to explain why certain interventions fit. Until then, keep the study in your back pocket when families ask, “Is there a lab test for autism?”